174 related articles for article (PubMed ID: 32536823)
1. Identification of methylation-driven genes related to the prognosis of papillary renal cell carcinoma: a study based on The Cancer Genome Atlas.
Liu Z; Wan Y; Yang M; Qi X; Dong Z; Huang J; Xu J
Cancer Cell Int; 2020; 20():235. PubMed ID: 32536823
[TBL] [Abstract][Full Text] [Related]
2. LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches.
Wang J; Zhao H; Dong H; Zhu L; Wang S; Wang P; Ren Q; Zhu H; Chen J; Lin Z; Cheng Y; Qian B; Zhang Y; Jia R; Wu W; Lu J; Tan J
J Cancer; 2019; 10(26):6726-6737. PubMed ID: 31777602
[No Abstract] [Full Text] [Related]
3. Identification of epigenetic methylation-driven signature and risk loci associated with survival for colon cancer.
Wang X; Zhang D; Zhang C; Sun Y
Ann Transl Med; 2020 Mar; 8(6):324. PubMed ID: 32355768
[TBL] [Abstract][Full Text] [Related]
4. Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma.
Chen Y; Wang J; Zhou H; Huang Z; Qian L; Shi W
Biomed Res Int; 2021; 2021():6628391. PubMed ID: 34222478
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of methylation-driven genes prognostic signature for recurrence of laryngeal squamous cell carcinoma by integrated bioinformatics analysis.
Cui J; Wang L; Zhong W; Chen Z; Chen J; Yang H; Liu G
Cancer Cell Int; 2020; 20():472. PubMed ID: 33005105
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide screening of abberant methylated drivers combined with relative risk loci in bladder cancer.
Zhang C; Shen K; Zheng Y; Qi F; Luo J
Cancer Med; 2020 Jan; 9(2):768-782. PubMed ID: 31794632
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinoma.
Zhang C; Zheng Y; Li X; Hu X; Qi F; Luo J
Ann Transl Med; 2019 Sep; 7(18):427. PubMed ID: 31700863
[TBL] [Abstract][Full Text] [Related]
8. Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas.
Lu T; Chen D; Wang Y; Sun X; Li S; Miao S; Wo Y; Dong Y; Leng X; Du W; Jiao W
Cancer Cell Int; 2019; 19():52. PubMed ID: 30886542
[TBL] [Abstract][Full Text] [Related]
9. Identification of methylation driver genes for predicting the prognosis of pancreatic cancer patients based on whole-genome DNA methylation sequencing technology.
Song C; Wang G; Liu M; Xu Z; Liang X; Ding K; Chen Y; Wang W; Lou W; Liu L
Heliyon; 2024 May; 10(9):e29914. PubMed ID: 38737285
[TBL] [Abstract][Full Text] [Related]
10. Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis.
Wang Y; Yan K; Lin J; Wang J; Zheng Z; Li X; Hua Z; Bu Y; Shi J; Sun S; Li X; Liu Y; Bi J
Aging (Albany NY); 2020 Nov; 12(21):21854-21873. PubMed ID: 33154194
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma.
Singh NP; Vinod PK
Mol Genet Genomics; 2020 May; 295(3):807-824. PubMed ID: 32185457
[TBL] [Abstract][Full Text] [Related]
12. Methylation-Driven Genes Identified as Novel Prognostic Indicators for Thyroid Carcinoma.
Lv L; Cao L; Hu G; Shen Q; Wu J
Front Genet; 2020; 11():294. PubMed ID: 32296463
[TBL] [Abstract][Full Text] [Related]
13. Identification of 4-methylation driven genes based prognostic signature in thyroid cancer: an integrative analysis based on the methylmix algorithm.
Chen Z; Liu X; Liu F; Zhang G; Tu H; Lin W; Lin H
Aging (Albany NY); 2021 Aug; 13(16):20164-20178. PubMed ID: 34456184
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Novel DNA Methylation-Driven Gene Based Molecular Classification and Predictive Model for Overall Survival and Immunotherapy Response in Patients With Glioblastoma: A Multiomic Analysis.
Wang Z; Gao L; Guo X; Lian W; Deng K; Xing B
Front Cell Dev Biol; 2020; 8():576996. PubMed ID: 33015072
[TBL] [Abstract][Full Text] [Related]
15. m
Chen L; Hu B; Song X; Wang L; Ju M; Li Z; Zhou C; Zhang M; Wei Q; Guan Q; Jiang L; Chen T; Wei M; Zhao L
Front Oncol; 2021; 11():598017. PubMed ID: 33796449
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics analysis to screen DNA methylation-driven genes for prognosis of patients with bladder cancer.
Zhou Q; Chen Q; Chen X; Hao L
Transl Androl Urol; 2021 Sep; 10(9):3604-3619. PubMed ID: 34733656
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of DNA Methylation-Driven Genes in Clear Cell Renal Cell Carcinoma: A Study Based on Methylation and Transcriptome Analyses.
Hu M; Xie J; Hou H; Liu M; Wang J
Dis Markers; 2020; 2020():8817652. PubMed ID: 32733620
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of ubiquitin-proteasome system related genes as a prognostic signature for papillary renal cell carcinoma.
Zhang X; Liu X; Xiong R; An HX
Aging (Albany NY); 2022 Nov; 14(23):9599-9616. PubMed ID: 36385010
[TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of a Ferroptosis-Related Signature for Predicting Prognosis and Immune Microenvironment in Papillary Renal Cell Carcinoma.
Da Q; Ren M; Huang L; Qu J; Yang Q; Xu J; Ma Q; Mao X; Cai Y; Zhao D; Luo J; Yan Z; Sun L; Ouyang K; Zhang X; Han Z; Liu J; Wang T
Int J Gen Med; 2022; 15():2963-2977. PubMed ID: 35313551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
